Geoffrey W. Coombs
- Clinical Biochemistry top 0.02%
- Bacterial Identification and Susceptibility Testing 118
- Infectious Diseases top 0.1%
- Antimicrobial Resistance in Staphylococcus 157
-
- Antibiotic Use and Resistance 20
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 30
- Microbiology top 1%
-
- Bacterial biofilms and quorum sensing 65
-
- Streptococcal Infections and Treatments 40
-
- Infective Endocarditis Diagnosis and Management 25
- Urinary Tract Infections Management 8
- Co-authors
- Frances O’BrienGraeme R. NimmoJulie PearsonBenjamin P. HowdenJan BellJohn TurnidgeStanley PangWarren B. Grubb
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Nucleic Acids Research (1 paper)PLoS ONE (9 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Geoffrey W. Coombs
204 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Clinical Biochemistry 3.0k
- Infectious Diseases 5.1k
- Applied Microbiology and Biotechnology 347
- Molecular Medicine 775
- Microbiology 380
Countries citing papers authored by Geoffrey W. Coombs
This map shows the geographic impact of Geoffrey W. Coombs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey W. Coombs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey W. Coombs more than expected).
Fields of papers citing papers by Geoffrey W. Coombs
This network shows the impact of papers produced by Geoffrey W. Coombs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey W. Coombs. The network helps show where Geoffrey W. Coombs may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Geoffrey W. Coombs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 14 | |
| 4 | 2023 | 15 | |
| 5 | 2023 | 6 | |
| 6 | Fosfomycin susceptibility of Escherichia coli urinary tract infection isolates from Australia | 2021 | 1 |
| 7 | 2020 | 10 | |
| 8 | 2020 | 11 | |
| 9 | 2019 | 4 | |
| 10 | 2017 | 35 | |
| 11 | 2017 | 53 | |
| 12 | 2016 | 20 | |
| 13 | 2016 | 103 | |
| 14 | 2015 | 8 | |
| 15 | Cousins, siblings, or copies: the genomics of recurrentStaphylococcus aureusinfections in chronic rhinosinusitis | 2014 | 2 |
| 16 | 2014 | 29 | |
| 17 | 2014 | 24 | |
| 18 | 2011 | 24 | |
| 19 | 2009 | 26 | |
| 20 | 2008 | 21 |
About Geoffrey W. Coombs
Geoffrey W. Coombs is a scholar working on Clinical Biochemistry, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 208 papers that have together received 6.9k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (157 papers), Bacterial Identification and Susceptibility Testing (118 papers), Bacterial biofilms and quorum sensing (65 papers), Streptococcal Infections and Treatments (40 papers), Antibiotic Resistance in Bacteria (30 papers), Infective Endocarditis Diagnosis and Management (25 papers), Antibiotic Use and Resistance (20 papers) and Urinary Tract Infections Management (8 papers). The work is most often cited by research in Clinical Biochemistry (3.0k citations), Infectious Diseases (5.1k citations) and Applied Microbiology and Biotechnology (347 citations). Geoffrey W. Coombs has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Frances O’Brien, Graeme R. Nimmo, Julie Pearson, Benjamin P. Howden, Jan Bell, John Turnidge, Stanley Pang, Warren B. Grubb, Keryn Christiansen and John W. Pearman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.